{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:47:12Z","timestamp":1791521232309,"version":"4.3.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.anai.2022.08.996","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:28:35Z","timestamp":1662510515000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Tryptase in type I hypersensitivity"],"prefix":"10.1016","volume":"130","author":[{"given":"Mo\u00efse","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-9408","authenticated-orcid":false,"given":"Joana","family":"Vitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imr.12629","article-title":"Non-IgE mediated mast cell activation","volume":"282","author":"Redegeld","year":"2018","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.anai.2022.08.996_bib0005","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jaci.2022.01.030","article-title":"Selected recent advances in understanding the role of human mast cells in health and disease","volume":"149","author":"Levi-Schaffer","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.08.996_bib0006","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.it.2020.06.006","article-title":"Cardiac mast cells: underappreciated immune cells in cardiovascular homeostasis and disease","volume":"41","author":"Varricchi","year":"2020","journal-title":"Trends Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.08.996_bib0007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anai.2021.07.025","article-title":"Mast cell disorders: a framework of allergy and hematology symptoms leading to personalized treatments","volume":"127","author":"Castells","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.anai.2022.08.996_bib0008","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.jaip.2021.12.031","article-title":"Elevated basal serum tryptase: disease distribution and variability in a regional health system","volume":"10","author":"Waters","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0009","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/all.14881","article-title":"The ingenious mast cell: contemporary insights into mast cell behavior and function","volume":"77","author":"Dahlin","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2022.08.996_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000500088","article-title":"Physiological roles of mast cells: collegium internationale Allergologicum update 2019","volume":"179","author":"Varricchi","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"4S","key":"10.1016\/j.anai.2022.08.996_bib0011","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaci.2019.02.004","article-title":"Regulation of the pleiotropic effects of tissue-resident mast cells","volume":"144","author":"Huber","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.08.996_bib0012","article-title":"New perspectives on the origins and heterogeneity of mast cells","author":"St John","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.anai.2022.08.996_bib0013","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"issue":"12","key":"10.1016\/j.anai.2022.08.996_bib0014","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/all.14908","article-title":"The role of allergen-specific IgE, IgG and IgA in allergic disease","volume":"76","author":"Shamji","year":"2021","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2022.08.996_bib0015","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jaip.2022.05.007","article-title":"Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium","volume":"10","author":"Valent","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0016","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: Anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.anai.2022.08.996_bib0017","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.anai.2022.08.996_bib0018","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0019","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/ijms22052458","article-title":"Genetic regulation of tryptase production and clinical impact: hereditary alpha tryptasemia, mastocytosis and beyond","volume":"22","author":"Sprinzl","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.anai.2022.08.996_bib0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.anai.2021.08.009","article-title":"Clinical relevance of inherited genetic differences in human tryptases: hereditary alpha-tryptasemia and beyond","volume":"127","author":"Glover","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0021","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2022.08.996_bib0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa1500611","article-title":"Vibratory urticaria associated with a missense variant in ADGRE2","volume":"374","author":"Boyden","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2022.08.996_bib0071","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.anai.2022.08.996_bib0072","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jaip.2022.04.041","article-title":"Recent developments in the field of mast cell disorders: classification, prognostication, and management","volume":"10","author":"Valent","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2022.08.996_bib0073","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"10.1016\/j.anai.2022.08.996_bib0038","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.anai.2022.08.996_bib0042","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0047","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/ACI.0000000000000768","article-title":"Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review","volume":"21","author":"Sabato","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2022.08.996_bib0022","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/185846a0","article-title":"Histochemical demonstration of a species-specific trypsin-like enzyme in mast cells","volume":"185","author":"Glenner","year":"1960","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.anai.2022.08.996_bib0023","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0024","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.08.996_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0026","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0027","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/ijms22052684","article-title":"Mediator-related symptoms and anaphylaxis in children with mastocytosis","volume":"22","author":"Brockow","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20%\u00a0+\u00a02 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.anai.2022.08.996_bib0064","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2022.08.996_bib0028","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.138.8.2611","article-title":"Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells","volume":"138","author":"Schwartz","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2022.08.996_bib0029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","article-title":"Mast cell tryptases in allergic inflammation and immediate hypersensitivity","volume":"72","author":"Lyons","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2009.07.026","article-title":"Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations","volume":"124","author":"Trivedi","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2022.08.996_bib0031","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.138.7.2184","article-title":"Evaluation of human peripheral blood leukocytes for mast cell tryptase","volume":"138","author":"Castells","year":"1987","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1067\/mai.2002.121454","article-title":"Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils","volume":"109","author":"Foster","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.08.996_bib0033","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","article-title":"Expression of alpha-tryptase and beta-tryptase by human basophils","volume":"113","author":"Jogie-Brahim","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2022.08.996_bib0034","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2006.02.026","article-title":"Tryptase genetics and anaphylaxis","volume":"117","author":"Caughey","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"10.1016\/j.anai.2022.08.996_bib0035","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1074\/jbc.M117.812016","article-title":"Dual functionality of beta-tryptase protomers as both proteases and cofactors in the active tetramer","volume":"293","author":"Maun","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anai.2022.08.996_bib0036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coi.2021.03.015","article-title":"The high affinity IgE receptor: a signaling update","volume":"72","author":"Blank","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"537","key":"10.1016\/j.anai.2022.08.996_bib0037","doi-asserted-by":"crossref","first-page":"eaan4350","DOI":"10.1126\/scisignal.aan4350","article-title":"Tomosyn functions as a PKC\u03b4-regulated fusion clamp in mast cell degranulation","volume":"11","author":"Madera-Salcedo","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.anai.2022.08.996_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.652077","article-title":"Cytoskeletal transport, reorganization, and fusion regulation in mast cell-stimulus secretion coupling","volume":"9","author":"Menasche","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.anai.2022.08.996_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918305","article-title":"Mast cell and basophil granule proteases - in vivo targets and function","volume":"13","author":"Hellman","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0041","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2019.09.009","article-title":"An allosteric anti-tryptase antibody for the treatment of mast cell-mediated severe asthma","volume":"179","author":"Maun","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0043","doi-asserted-by":"crossref","first-page":"e97014","DOI":"10.1371\/journal.pone.0097014","article-title":"Circulating tryptase as a marker for subclinical atherosclerosis in obese subjects","volume":"9","author":"Moreno","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0044","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12948-015-0013-0","article-title":"Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years","volume":"13","author":"Pastorello","year":"2015","journal-title":"Clin Mol Allergy"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/eci.12622","article-title":"Serum tryptase concentration and progression to end-stage renal disease","volume":"46","author":"Jesky","year":"2016","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"10.1016\/j.anai.2022.08.996_bib0046","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/biomedicines8120606","article-title":"Development of a biomarker panel to distinguish risk of progressive chronic kidney disease","volume":"8","author":"Owens","year":"2020","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0048","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cea.12627","article-title":"Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis","volume":"46","author":"Bulai Livideanu","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2022.08.996_bib0049","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.07.019","article-title":"Allergy and allergic mediators in tears","volume":"117","author":"Leonardi","year":"2013","journal-title":"Exp Eye Res"},{"issue":"3","key":"10.1016\/j.anai.2022.08.996_bib0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000519374","article-title":"Detection of salivary tryptase levels in children following oral food challenges","volume":"183","author":"de Weger","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"10.1016\/j.anai.2022.08.996_bib0051","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.3390\/jcm11102749","article-title":"A non-invasive neonatal signature predicts later development of atopic diseases","volume":"11","author":"Sereme","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.anai.2022.08.996_bib0052","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000260080","article-title":"Tryptase is not cleared by the kidneys into the urine","volume":"152","author":"Simon","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0053","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI114051","article-title":"Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis","volume":"83","author":"Schwartz","year":"1989","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.anai.2022.08.996_bib0054","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.jaip.2021.03.011","article-title":"Use and interpretation of acute and baseline tryptase in perioperative hypersensitivity and anaphylaxis","volume":"9","author":"Vitte","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.anai.2022.08.996_bib0056","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jaip.2022.05.003","article-title":"Incorporating tryptase genotyping into the workup and diagnosis of mast cell diseases and reactions","volume":"10","author":"Lyons","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2022.08.996_bib0061","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1399-3038.2011.01166.x","article-title":"Total serum tryptase levels are higher in young infants","volume":"22","author":"Belhocine","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0058","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/CCLM.2010.124","article-title":"Factors influencing serum total tryptase concentrations in a general adult population","volume":"48","author":"Gonzalez-Quintela","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000327535","article-title":"Determinants of serum tryptase in a general population: the relationship of serum tryptase to obesity and asthma","volume":"157","author":"Fenger","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2022.08.996_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/cea.14195","article-title":"Tryptase reference values in a Swedish middle-aged general population and association with diabetes mellitus","author":"Vitte","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"10.1016\/j.anai.2022.08.996_bib0062","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1111\/all.15369","article-title":"Tryptase reference ranges are age-dependent in a large population-based cohort","volume":"77","author":"Slot","year":"2022","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2022.08.996_bib0074","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/acer.12682","article-title":"Serum concentrations of mast cell tryptase are reduced in heavy drinkers","volume":"39","author":"Beceiro","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.anai.2022.08.996_bib0057","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2021.06.019","article-title":"Inherited and acquired determinants of serum tryptase levels in humans","volume":"127","author":"Lyons","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0063","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.anai.2022.07.025","article-title":"Temporal variation of tryptase and interlaboratory variability","volume":"12","author":"Ritter","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2022.08.996_bib0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2022.08.996_bib0066","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaip.2019.08.022","article-title":"Mast cell activation syndrome: tools for diagnosis and differential diagnosis","volume":"8","author":"Weiler","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2022.08.996_bib0067","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2010.04287.x","article-title":"Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay","volume":"163","author":"Sargur","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.anai.2022.08.996_bib0068","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2340\/00015555-1245","article-title":"Impact of age and heterophilic interference on the basal serum tryptase, a risk indication for anaphylaxis, in 1,092 dermatology patients","volume":"92","author":"Schliemann","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.anai.2022.08.996_bib0069","first-page":"329","article-title":"Performance criteria for the verification of IgE and tryptase assay methods: recommendations from the AllergoBioNet network","volume":"78","author":"Sarrat","year":"2020","journal-title":"Ann Biol Clin"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622017094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120622017094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:30:45Z","timestamp":1761053445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120622017094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1081120622017094"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2022.08.996","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptase in type I hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2022.08.996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}